Girish Thunga

1.9k total citations · 1 hit paper
115 papers, 783 citations indexed

About

Girish Thunga is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Girish Thunga has authored 115 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 21 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Girish Thunga's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Poisoning and overdose treatments (11 papers) and Diabetes Treatment and Management (11 papers). Girish Thunga is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Poisoning and overdose treatments (11 papers) and Diabetes Treatment and Management (11 papers). Girish Thunga collaborates with scholars based in India, Australia and United States. Girish Thunga's co-authors include Sreedharan Nair, Viji Pulikkel Chandran, Surulivelrajan Mallayasamy, Vijayanarayana Kunhikatta, Leelavathi D Acharya, Amir Sasan Mozaffari Nejad, Muhammed Rashid, Rashmi Shetty, Sohil Khan and Muhammed Rashid and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Environmental Research and Public Health.

In The Last Decade

Girish Thunga

98 papers receiving 745 citations

Hit Papers

Adverse drug reactions of GLP-1 agonists: A systematic re... 2022 2026 2023 2024 2022 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adverse drug reactions of GLP-1 agonists: A systematic review of case reports
    2022 100 citations Girish Thunga, Viji Pulikkel Chandran et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Girish Thunga India 13 207 116 99 79 75 115 783
Syed Wasif Gillani United Arab Emirates 14 201 1.0× 134 1.2× 109 1.1× 48 0.6× 18 0.2× 97 693
Dyah Aryani Perwitasari Indonesia 17 168 0.8× 183 1.6× 115 1.2× 82 1.0× 29 0.4× 166 962
Ivor Katz South Africa 16 73 0.4× 127 1.1× 52 0.5× 69 0.9× 36 0.5× 34 1.0k
Majid Khadem‐Rezaiyan Iran 14 125 0.6× 142 1.2× 134 1.4× 214 2.7× 17 0.2× 132 969
Meseret Derbew Molla Ethiopia 16 99 0.5× 113 1.0× 64 0.6× 87 1.1× 19 0.3× 47 942
Farshid Alaeddini Iran 19 112 0.5× 257 2.2× 197 2.0× 133 1.7× 137 1.8× 71 1.2k
Alison Richards United Kingdom 15 46 0.2× 118 1.0× 143 1.4× 61 0.8× 36 0.5× 27 960
S. Nigam United States 16 188 0.9× 149 1.3× 122 1.2× 64 0.8× 15 0.2× 34 808
Mohammad Khajedaluee Iran 13 147 0.7× 167 1.4× 92 0.9× 155 2.0× 21 0.3× 72 807
Antonio Segura Spain 18 262 1.3× 131 1.1× 207 2.1× 234 3.0× 23 0.3× 34 1.2k

Countries citing papers authored by Girish Thunga

Since Specialization
Citations

This map shows the geographic impact of Girish Thunga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Girish Thunga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Girish Thunga more than expected).

Fields of papers citing papers by Girish Thunga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Girish Thunga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Girish Thunga. The network helps show where Girish Thunga may publish in the future.

Co-authorship network of co-authors of Girish Thunga

This figure shows the co-authorship network connecting the top 25 collaborators of Girish Thunga. A scholar is included among the top collaborators of Girish Thunga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Girish Thunga. Girish Thunga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rashid, Muhammed, et al.. (2025). Machine Learning in Predicting Child Malnutrition: A Meta-Analysis of Demographic and Health Surveys Data. International Journal of Environmental Research and Public Health. 22(3). 449–449. 2 indexed citations
3.
4.
Rashid, Muhammed, et al.. (2024). Efficacy of corticosteroids in COVID-19: An evidence-based approach from the published randomized controlled trials. Clinical Epidemiology and Global Health. 33. 101867–101867.
5.
6.
Chandran, Viji Pulikkel, Muhammed Rashid, Vijayanarayana Kunhikatta, et al.. (2023). The significance of APACHE II as a predictor of mortality in paraquat poisoning: A systematic review and meta-analysis. Journal of Forensic and Legal Medicine. 97. 102548–102548. 5 indexed citations
7.
Thunga, Girish, et al.. (2023). Economic Burden of Mosquito-Borne Diseases in Low- and Middle-Income Countries: Protocol for a Systematic Review. JMIR Research Protocols. 12. e50985–e50985. 19 indexed citations
8.
Rashid, Muhammed, Viji Pulikkel Chandran, Vijayanarayana Kunhikatta, et al.. (2022). Artificial intelligence in differentiating tropical infections: A step ahead. PLoS neglected tropical diseases. 16(6). e0010455–e0010455. 5 indexed citations
9.
Rashid, Muhammed, et al.. (2022). Proton pump inhibitors use and risk of inflammatory bowel diseases: a meta-analysis of observational studies. Medicine and Pharmacy Reports. 95(4). 357–369. 12 indexed citations
10.
Chandran, Viji Pulikkel, Muhammed Rashid, Sohil Khan, et al.. (2022). Mobile applications in medical education: A systematic review and meta-analysis. PLoS ONE. 17(3). e0265927–e0265927. 61 indexed citations
11.
Kunhikatta, Vijayanarayana, et al.. (2022). Use of histamine‐2 receptor antagonists and risk of inflammatory bowel diseases: A systematic review and meta‐analysis of observational studies. Journal of Clinical Pharmacy and Therapeutics. 47(8). 1103–1111. 8 indexed citations
12.
Rashid, Muhammed, et al.. (2022). Artificial intelligence in acute respiratory distress syndrome: A systematic review. Artificial Intelligence in Medicine. 131. 102361–102361. 14 indexed citations
13.
Rashid, Muhammed, Manik Chhabra, Viji Pulikkel Chandran, et al.. (2022). Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens–Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis. Seizure. 102. 36–50. 9 indexed citations
14.
Nair, Sreedharan, et al.. (2022). Impact of Diabetes in COVID-19 Associated Mucormycosis and its Management:A Non-Systematic Literature Review. Current Diabetes Reviews. 19(3). e240222201411–e240222201411. 4 indexed citations
15.
16.
Unnikrishnan, M.K., et al.. (2021). Effectiveness of blended learning in pharmacy education: A systematic review and meta-analysis. PLoS ONE. 16(6). e0252461–e0252461. 33 indexed citations
17.
Rashid, Muhammed, et al.. (2020). Survival Benefits of N-Acetylcysteine in Rodenticide Poisoning: Retrospective Evidence from an Indian Tertiary Care Setting. PubMed. 16(2). 201–208. 6 indexed citations
18.
Thunga, Girish, et al.. (2016). STUDY ON PRESCRIBING PATTERN OF ANTI-DIABETIC DRUGS AMONG TYPE 2 DIABETES PATIENTS WITH COMPLICATION IN SOUTH INDIAN TEACHING HOSPITAL. Asian Journal of Pharmaceutical and Clinical Research. 9(13). 194–197. 8 indexed citations
19.
Thunga, Girish, et al.. (2014). PHARMACOKINETIC STUDIES ON OXIMES IN ORGANOPHOSPHATE POISONING: A MINI REVIEW. 3(3). 120–123. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Syed Wasif Gillani Breakdown of academic impact, for papers by Dyah Aryani Perwitasari Breakdown of academic impact, for papers by Ivor Katz Breakdown of academic impact, for papers by Majid Khadem‐Rezaiyan Breakdown of academic impact, for papers by Meseret Derbew Molla Breakdown of academic impact, for papers by Farshid Alaeddini Breakdown of academic impact, for papers by Alison Richards Breakdown of academic impact, for papers by S. Nigam Breakdown of academic impact, for papers by Mohammad Khajedaluee Breakdown of academic impact, for papers by Antonio Segura
Rankless by CCL
2026